ELANE and acute respiratory distress syndrome: It has recently been hypothesized that neutrophil elastase inhibitors could be used to treat acute respiratory distress syndrome (ARDS) caused by COVID-19 infection, but their effective use is yet unproven, and more clinical studies should be conducted to evaluate the response and effectiveness of these types of inhibitors in COVID-19 patients [14].